The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...